Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

(2011) Rebecca Schennach-Wolff et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

An early improvement threshold to predict response and remission in first-episode schizophrenia

(2010) R. Schennach-Wolff et al.   BRITISH JOURNAL OF PSYCHIATRY

Antipsychotic Drug Treatment in First-Episode Psychosis

(2010) Eske M. Derks et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: Analyses of ziprasidone clinical study data

(2010) Prakash Masand et al.   SCHIZOPHRENIA RESEARCH

Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study

(2009) M. Jäger et al.   EUROPEAN PSYCHIATRY

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

(2009) Bruce J Kinon et al.   NEUROPSYCHOPHARMACOLOGY

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆

(2008) B KINON et al.   SCHIZOPHRENIA RESEARCH

Prediction of symptom remission in schizophrenia during inpatient treatment

(2008) Markus Jäger et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY